Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy and Safety of Eslicarbazepine Acetate as Adjunctive Therapy for Refractory Partial Epilepsy
This study has been completed.
Study NCT00957372   Information provided by Bial - Portela C S.A.

First Received on August 10, 2009.   Last Updated on June 18, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Partial Epilepsy
Additional conditions recognized in this trial
Epilepsies, Partial
Epilepsy
More general conditions related to this trial
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Interventions listed in this trial
eslicarbazepine acetate
placebo
Sponsors listed in this trial
Bial - Portela C S.A.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services